LuciTala 0.25 mg Capsule
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Description
LuciTala 0.25 mg capsules contain talazoparib, a PARP inhibitor. It is used for germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer, and with enzalutamide for HRR gene-mutated metastatic castration-resistant prostate cancer. LuciTala is a prescription-only medicine; treatment, dose and monitoring should be decided and supervised by the prescribing specialist. Strength: 0.25 mg per capsule. Pack: 60 Capsules. Manufacturer: Lucius Pharmaceuticals (Laos).
Related Products
-
LuciCeno 50 mg Tablet
Price on request
Request pricing -
LuciCeno 12.5 mg Tablet
Price on request
Request pricing -
LuciRevu 110 mg Tablet
Price on request
Request pricing -
LuciRevu 25 mg Tablet
Price on request
Request pricing -
LuciNfig 25 mg Capsule
Price on request
Request pricing -
LuciVande 100 mg Tablet
Price on request
Request pricing
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import
Only logged in customers who have purchased this product may leave a review.
Reviews
Clear filtersThere are no reviews yet.